<SEC-DOCUMENT>0001654954-19-005037-index.html : 20190430 <SEC-HEADER>0001654954-19-005037.hdr.sgml : 20190430 <ACCEPTANCE-DATETIME>20190430163525 ACCESSION NUMBER: 0001654954-19-005037 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20190430 DATE AS OF CHANGE: 20190430 EFFECTIVENESS DATE: 20190430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 19782356 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 </SEC-HEADER> <DOCUMENT> <TYPE>DEFA14A <SEQUENCE>1 <FILENAME>finalregisterednoticecard.htm <DESCRIPTION>DEFA14A <TEXT> Document 1 - file: finalregisterednoticecard.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>finalntc2019pg3.jpg <DESCRIPTION>IMAGE <TEXT> Document 2 - file: finalntc2019pg3.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>finalntc2019pg4.jpg <DESCRIPTION>IMAGE <TEXT> Document 3 - file: finalntc2019pg4.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>finalntc2019tgtherapeutic.jpg <DESCRIPTION>IMAGE <TEXT> Document 4 - file: finalntc2019tgtherapeutic.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>finalntc2019tgtherapeutic000.jpg <DESCRIPTION>IMAGE <TEXT> Document 5 - file: finalntc2019tgtherapeutic000.jpg
</DOCUMENT> </SEC-DOCUMENT>